Press release
Eczema Pipeline Outlook Report 2024 | LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, AstraZeneca, Kyowa Kirin, and Others
DelveInsight's, "Eczema Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the Eczema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eczema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Key Takeaways from the Eczema Pipeline Report
• DelveInsight's Eczema pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for Eczema treatment.
• The leading companies working in the Eczema Market include Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries, Brickell Biotech Inc., Dermira, AstraZeneca, Kyowa Kirin, UCB Biopharma, Arcutis Biotherapeutics, and others.
• Promising Eczema Pipeline Therapies in the various stages of development include alitretinoin, Arctiva, KY1005, Dupilumab, Lebrikizumab, Baricitinib, MEDI9929, Midazolam, Omeprazole, and others.
• December 2023: LEO Pharma announced a study of Phase 3 clinical trials for Tralokinumab. The purpose of this study is to test if treatment with tralokinumab is safe and effectful to treat moderate-to-severe atopic hand eczema. This will be judged by a range of assessments that rate the severity and extent of atopic hand eczema and its symptoms, as well as general health status and quality of life.
• November 2023: Regeneron Pharmaceuticals announced a study of Phase 4 clinical trials for Dupilumab. The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis. Atopic dermatitis, also referred to as eczema, is a condition that causes the skin to become itchy, dry, and cracked. From the previous studies on the study drug, it is seen that the study drug has an acceptable safety and effectiveness in participants with atopic dermatitis. The aim of this study is to get additional information on the safety and effectiveness of the study drug, particularly the information on aspects of atopic dermatitis in skin of color participants.
Request a sample and discover the recent advances in Eczema Treatment Drugs @ Eczema Pipeline Outlook Report- https://www.delveinsight.com/report-store/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
In the Eczema pipeline report, a detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Eczema collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Eczema Overview
Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People with the disease tend to have dry, itchy skin that is prone to infection.
Find out more about Eczema Treatment Landscape @ Drugs for Eczema Treatment- https://www.delveinsight.com/sample-request/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Eczema Emerging Drugs Profile
• Amlitelimab: Kymab
• BX 005: BiomX
• LP 0145: LEO Pharma
Eczema Pipeline Therapeutics Assessment
There are approx. 100+ key companies which are developing the therapies for Eczema. The Eczema companies which have their Eczema drug candidates in the most advanced stage, i.e. phase II include, LEO Pharma.
DelveInsight's Eczema Pipeline Report covers around 100+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Eczema pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Eczema Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule
Learn more about the emerging Eczema Pipeline Therapies @ Eczema Clinical Trials Assessment- https://www.delveinsight.com/sample-request/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Eczema Pipeline Report
• Coverage- Global
• Eczema Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Eczema Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Eczema Companies- Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries, Brickell Biotech Inc., Dermira, AstraZeneca, Kyowa Kirin, UCB Biopharma, Arcutis Biotherapeutics, and others.
• Eczema Pipeline Therapies- alitretinoin, Arctiva, KY1005, Dupilumab, Lebrikizumab, Baricitinib, MEDI9929, Midazolam, Omeprazole, and others.
Dive deep into rich insights for new drugs for Eczema Treatment, Visit @ Eczema Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Eczema: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Eczema- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug name : Company name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Amlitelimab: Kymab
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Drug name : Company name
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name : Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Eczema Key Companies
21. Eczema Key Products
22. Eczema- Unmet Needs
23. Eczema- Market Drivers and Barriers
24. Eczema- Future Perspectives and Conclusion
25. Eczema Analyst Views
26. Eczema Key Companies
27. Appendix
For further information on the Eczema Pipeline Therapeutics, reach out @ Eczema Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Links-
https://minibookmarks.com/story16790703/viscosupplementation-devices-market
https://friendlybookmark.com/story16779867/viscosupplementation-devices-market
https://indexedbookmarks.com/story16732026/viscosupplementation-devices-market
https://bookmarksystem.com/story16736789/viscosupplementation-devices-market
https://bookmarkusers.com/story16717248/viscosupplementation-devices-market
https://bookmarkspiral.com/story16835789/viscosupplementation-devices-market
https://bookmarkdistrict.com/story16699965/viscosupplementation-devices-market
https://bookmark-search.com/story16774732/viscosupplementation-devices-market
https://bookmark-nation.com/story16737294/viscosupplementation-devices-market
https://bookmarkextent.com/story18176631/viscosupplementation-devices-market
https://bookmarkrange.com/story17912647/viscosupplementation-devices-market
https://gatherbookmarks.com/story17254441/viscosupplementation-devices-market
https://bookmarkstumble.com/story18188181/viscosupplementation-devices-market
https://bookmarkstime.com/story16989308/viscosupplementation-devices-market
https://bookmark-rss.com/story16752908/viscosupplementation-devices-market
https://bookmarklinkz.com/story16811460/viscosupplementation-devices-market
https://tbookmark.com/story16762661/viscosupplementation-devices-market
https://xyzbookmarks.com/story16747962/viscosupplementation-devices-market
https://7bookmarks.com/story16750109/viscosupplementation-devices-market
https://socialmarkz.com/story6939306/viscosupplementation-devices-market
https://johsocial.com/story6827517/viscosupplementation-devices-market
https://bouchesocial.com/story18400486/viscosupplementation-devices-market
https://iowa-bookmarks.com/story12371646/viscosupplementation-devices-market
https://bookmarketmaven.com/story17090881/viscosupplementation-devices-market
https://bookmarkswing.com/story18040292/viscosupplementation-devices-market
https://bookmarkspring.com/story11428565/viscosupplementation-devices-market
https://bookmarksknot.com/story18266159/viscosupplementation-devices-market
https://bookmarkja.com/story18268520/viscosupplementation-devices-market
https://altbookmark.com/story18299435/viscosupplementation-devices-market
https://letusbookmark.com/story18150446/viscosupplementation-devices-market
https://trackbookmark.com/story18019007/viscosupplementation-devices-market
https://hindibookmark.com/story18197997/viscosupplementation-devices-market
https://bookmarkshq.com/story18077602/viscosupplementation-devices-market
https://nybookmark.com/story18145379/viscosupplementation-devices-market
https://socialmphl.com/story18407163/viscosupplementation-devices-market
https://sparxsocial.com/story6760075/viscosupplementation-devices-market
https://thesocialroi.com/story6458746/viscosupplementation-devices-market
https://socialdosa.com/story6495143/viscosupplementation-devices-market
https://sociallawy.com/story6746843/viscosupplementation-devices-market
https://sound-social.com/story6608014/viscosupplementation-devices-market
https://socialclubfm.com/story6931895/viscosupplementation-devices-market
https://socialskates.com/story17613587/viscosupplementation-devices-market
https://social-lyft.com/story6518087/viscosupplementation-devices-market
https://socialrator.com/story6805135/viscosupplementation-devices-market
https://nimmansocial.com/story6377783/viscosupplementation-devices-market
https://socialevity.com/story18336892/viscosupplementation-devices-market
https://dftsocial.com/story17386349/viscosupplementation-devices-market
https://throbsocial.com/story18405736/viscosupplementation-devices-market
https://bbsocialclub.com/story18351802/viscosupplementation-devices-market
https://socials360.com/story6826603/atopic-dermatitis-drug-market
https://socialwoot.com/story18204880/atopic-dermatitis-market
https://bookmarknap.com/story6708430/atopic-dermatitis-market-size
https://bookmarkinglive.com/story17474471/atopic-dermatitis-market-outlook
https://bookmarkmiracle.com/story18122275/atopic-dermatitis-market-forecast
https://bookmarkcork.com/story17330252/atopic-dermatitis-market-trends
https://lingeriebookmark.com/story6514956/atopic-dermatitis-treatment-market
https://bookmarkedblog.com/story17343349/atopic-dermatitis-drug-market
https://bookmarkspy.com/story18110258/atopic-dermatitis-companies
https://bookmarkvids.com/story17767704/atopic-dermatitis-market-outlook
https://fellowfavorite.com/story17736427/atopic-dermatitis-market-size
https://bookmarkshut.com/story17282007/atopic-dermatitis-drug-market
https://rotatesites.com/story17709868/atopic-dermatitis-drug-market
https://hubwebsites.com/story18061668/atopic-dermatitis-drug-market
https://binksites.com/story6421676/atopic-dermatitis-drug-market
https://sitesrow.com/story6493015/atopic-dermatitis-drug-market
https://mysitesname.com/story6456764/atopic-dermatitis-drug-market
https://sites2000.com/story6346560/atopic-dermatitis-market-trends
https://thejillist.com/story6633915/atopic-dermatitis-market-outlook
https://toplistar.com/story18347986/atopic-dermatitis-market-forecast
https://telebookmarks.com/story6794628/atopic-dermatitis-market-share
https://kingslists.com/story17759927/atopic-dermatitis-market-outlook
https://fatallisto.com/story6349655/atopic-dermatitis-market-size
https://worldlistpro.com/story18279926/atopic-dermatitis-market
https://health-lists.com/story17343512/atopic-dermatitis-market-size
https://webcastlist.com/story17648705/atopic-dermatitis-market-size
https://sirketlist.com/story18133623/atopic-dermatitis-market-outlook
https://listfav.com/story18081492/atopic-dermatitis-market-trends
https://classifylist.com/story18357465/atopic-dermatitis-market-forecast
https://icelisting.com/story17650330/atopic-dermatitis-market-size
https://210list.com/story17287877/atopic-dermatitis-treatment-market
https://hylistings.com/story17683127/atopic-dermatitis-treatment-market
https://mediajx.com/story18373882/fertility-monitoring-devices-market
https://thefairlist.com/story6660731/fertility-monitoring-devices-market-forecast
https://45listing.com/story18355876/fertility-monitoring-devices-market-outlook
https://funny-lists.com/story17699150/fertility-monitoring-devices-market-size
https://getidealist.com/story18323850/fertility-monitoring-devices-market
https://seolistlinks.com/story18079423/fertility-monitoring-devices-market-outlook
https://listbell.com/story6451094/fertility-monitoring-devices-market-size
https://wearethelist.com/story18386522/fertility-monitoring-devices-market
https://travialist.com/story6749378/fertility-monitoring-devices-market-size
https://wiishlist.com/story17323444/fertility-monitoring-devices-market
https://prbookmarkingwebsites.com/story18752231/fertility-monitoring-devices-market
https://germanydennydones.affiliatblogger.com/78073248/exploring-the-fertility-monitoring-devices-market-a-comprehensive-analysis-by-delveinsight
https://germanydennydones.free-blogz.com/73138753/exploring-the-fertility-monitoring-devices-market-insights-by-delveinsight
https://germanydennydones.ktwiki.com/604678/exploring_the_fertility_monitoring_devices_market_insights_by_delveinsight
https://germanydennydones.dekaronwiki.com/604062/exploring_the_fertility_monitoring_devices_market_insights_by_delveinsight
https://germanydennydones.sunderwiki.com/606031/exploring_the_fertility_monitoring_devices_market_a_comprehensive_analysis_by_delveinsight
https://germanydennydones.muzwiki.com/6805038/exploring_the_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.wikievia.com/9641397/exploring_the_growing_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.sasugawiki.com/6223809/exploring_the_growing_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.mysticwiki.com/603255/exploring_the_dynamics_of_the_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.azuria-wiki.com/602763/exploring_the_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.wonderkingwiki.com/603940/unveiling_the_booming_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.corpfinwiki.com/8097094/exploring_the_growth_trajectory_of_the_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.wikilima.com/492912/exploring_the_growth_trajectory_of_the_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.birderswiki.com/582398/exploring_the_dynamics_of_the_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.robhasawiki.com/10477847/exploring_the_booming_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.wikijm.com/603730/exploring_the_growing_medical_marijuana_market_insights_by_delveinsight
https://germanydennydones.yourkwikimage.com/601937/exploring_the_pelizaeus_merzbacher_disease_market_insights_by_delveinsight
https://germanydennydones.hazeronwiki.com/6941553/exploring_the_pelizaeus_merzbacher_disease_market_insights_by_delveinsight
https://germanydennydones.pages10.com/pelizaeus-merzbacher-disease-market-insights-by-delveinsight-61624162
https://germanydennydones.ampblogs.com/exploring-the-pelizaeus-merzbacher-disease-market-insights-by-delveinsight-62702491
https://germanydennydones.shotblogs.com/pelizaeus-merzbacher-disease-market-a-comprehensive-analysis-by-delveinsight-39879221
https://germanydennydones.tribunablog.com/exploring-the-pelizaeus-merzbacher-disease-market-insights-by-delveinsight-40134146
https://germanydennydones.blogocial.com/understanding-the-pelizaeus-merzbacher-disease-market-insights-by-delveinsight-61983920
https://germanydennydones.blogzet.com/unraveling-the-pelizaeus-merzbacher-disease-market-insights-by-delveinsight-40549740
https://germanydennydones.onesmablog.com/exploring-the-pelizaeus-merzbacher-disease-market-insights-by-delveinsight-66041223
https://germanydennydones.blogolize.com/exploring-the-pelizaeus-merzbacher-disease-market-insights-by-delveinsight-65376564
https://germanydennydones.blogminds.com/exploring-the-pelizaeus-merzbacher-disease-market-insights-by-delveinsight-23803304
https://germanydennydones.bloguetechno.com/exploring-the-pelizaeus-merzbacher-disease-market-insights-by-delveinsight-61384448
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/medical-marijuana-market-insight
https://www.delveinsight.com/report-store/pelizaeus-merzbacher-disease-market
https://www.delveinsight.com/report-store/radial-artery-compression-devices-market
https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eczema Pipeline Outlook Report 2024 | LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, AstraZeneca, Kyowa Kirin, and Others here
News-ID: 3438496 • Views: …
More Releases from DelveInsight Business Research LLP

Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…

Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…

DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…

Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Eczema
Global Parents for Eczema Research (GPER) Announces 2025 Childhood Eczema Preven …
Santa Barbara, CA, September 9, 2025 - A decade ago, Global Parents for Eczema Research (GPER) was founded with a simple but powerful mission: to reduce the suffering of children with eczema and to give parents a voice in shaping research priorities. Today, GPER is carrying that mission forward by directly funding innovative science to make rapid progress towards a cure and prevention.
GPER is excited to announce the recipients of…
Hand Eczema Market Massive Growth opportunity Ahead
Introduction
Hand eczema, a chronic inflammatory skin condition affecting the hands, is one of the most common occupational skin disorders worldwide. Characterized by itching, redness, scaling, and painful cracks, it can severely impair daily activities and quality of life. The condition is prevalent among healthcare workers, hairdressers, construction workers, and others exposed to irritants and allergens.
With increasing awareness of skin health, growth in dermatological research, and the introduction of novel therapies…
Codex Labs to Exhibit at the National Eczema Association's Eczema Expo 2025
Scottsdale, Ariz. - July 17th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a biotech skincare company focused on microbiome-friendly solutions, is honored to participate in the National Eczema Association's Eczema Expo 2025 [https://nationaleczema.org/eczema-expo/?gad_source=1&gad_campaignid=22351487646&gbraid=0AAAAAB0npNbWbfjE80zPi-DhIw2YfY2qF&gclid=CjwKCAjw3f_BBhAPEiwAaA3K5GPLZHZHEl6Qy8xrAj3hEWhfW7WDsCE-7pymOFKmLfLmr43e1AAXYhoC90YQAvD_BwE]. Taking place from July 24th to 27th at the Grand Hyatt Scottsdale Resort, individuals impacted by eczema will gather to learn from world-class medical experts and community leaders. The goal of the event is to provide you with support,…
Global Parents for Eczema Research (GPER) Awards Two Grants to Advance Childhood …
Santa Barbara, CA, October 15, 2024 - Global Parents for Eczema Research (GPER), a nonprofit organization dedicated to improving the lives of children suffering from eczema (atopic dermatitis, AD), announced the funding of two groundbreaking research projects as part of its 2024 Childhood Eczema Prevention Grant program. These grants will each provide up to $25,000 to support clinical research focused on preventing eczema in children.
Eczema affects up to 20% of…
Global Parents for Eczema Research (GPER) Announces Childhood Eczema Prevention …
Santa Barbara, CA, March 11, 2024 - Global Parents for Eczema Research (GPER) today announced the release of its Childhood Eczema Prevention Grant aimed at supporting innovative research studies focused on preventing pediatric atopic dermatitis (AD or "eczema"). This funding announcement is aimed at addressing the increasing prevalence of AD among children and at fostering research initiatives with the potential to mitigate the burden on children and families.
"We are dedicated…
Eczema Treatment Market During 2017 to 2025
Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive.…